IJ Pharmaceutical Research
Crossref
1. Disaccharide trehalose in experimental therapies for neurodegenerative disorders: Molecular targets and translational potential
- Alexander B. Pupyshev
- Tatyana P. Klyushnik
- Anna A. Akopyan
- Sandeep Kumar Singh
- Maria A. Tikhonova
2. Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
- Yumin Wang
- Luyan Gao
- Jichao Chen
- Qiang Li
- Liang Huo
- Yanchao Wang
- Hongquan Wang
- Jichen Du
3. A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
- Sibel Suzen
- Paolo Tucci
- Elisabetta Profumo
- Brigitta Buttari
- Luciano Saso
4. GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders
- Divya Soni
- Puneet Kumar
5. NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
- Juan A. Parga
- Ana I. Rodriguez-Perez
- Maria Garcia-Garrote
- Jannette Rodriguez-Pallares
- Jose L. Labandeira-Garcia
6. Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson’s Disease Rat Model
- Hany H. Arab
- Marwa M. Safar
- Nancy N. Shahin
7. Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
- Hilary Grosso Jasutkar
- Stephanie E. Oh
- M. Maral Mouradian
8. Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology
- Igor Pantic
- Jelena Cumic
- Sanja Radojevic Skodric
- Stefan Dugalic
- Claude Brodski